Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Sharir, Rinat ^a,b,c,d   Semo, Jonathan ^a,b,c   Shimoni, Sara ^a,b,d   Ben Mordechai, Tamar ^d   Landa Rouben, Natalie ^d   Maysel Auslender, Sofia ^a,b,d   Shaish, Aviv ^e   Entin Meer, Michal ^a,b,d   Keren, Gad ^c,d   George, Jacob ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXPERIMENTAL MYOCARDIAL INFARCTION; GENE DELETION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART VENTRICLE REMODELING; HEMOSTASIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFER; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SPLEEN CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; COCULTURE; DISEASE MODEL; HEART MUSCLE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; SPLEEN; T-LYMPHOCYTES, REGULATORY; VENTRICULAR REMODELING;

EID: 84914689028     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113653     Document Type: Article

References (45)

1. Cleland JG, Khand A, Clark A (2001) The heart failure epidemic: exactly how big is it? Eur Heart J 22: 623-626.
2. Sharpe N, Doughty R (1998) Epidemiology of heart failure and ventricular dysfunction. Lancet 352 Suppl 1: SI3-7.
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. (2009) Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 480-486.
4. Jugdutt BI (2003) Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108: 1395-1403.
5. Mann DL (1999) Mechanisms and models in heart failure: A combinatorial approach. Circulation 100: 999-1008.
6. Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988.
7. Nian M, Lee P, Khaper N, Liu P (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553.
8. Sun Y, Kiani MF, Postlethwaite AE, Weber KT (2002) Infarct scar as living tissue. Basic Res Cardiol 97: 343-347.
9. Frangogiannis NG (2006) The mechanistic basis of infarct healing. Antioxid Redox Signal 8: 1907-1939.
10. Gershon RK (1975) A disquisition on suppressor T cells. Transplant Rev 26: 170-185.
11. Gershon RK, Cohen P, Hencin R, Liebhaber SA (1972) Suppressor T cells. J Immunol 108: 586-590.
12. Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
13. Mor A, Planer D, Luboshits G, Afek A, Metzger S, et al. (2007) Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27: 893-900.
14. Mor A, Luboshits G, Planer D, Keren G, George J (2006) Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 27: 2530-2537.
15. Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG (2010) CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176: 2177-2187.
16. Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, et al. (2012) Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol 107: 1-17.
17. Ulrich Hofmann NB, Weirather J, Podolskkaya A, Bauersachs J, Ertl G, et al. (2012) Activation of CD4+ T-Lymphocytes Improves Wound Healing and Survival after Experimental Myocardial Infarction in Mice. Circulation.
18. Sharir R, Semo J, Shaish A, Landa-Rouben N, Entin-Meer M, et al. (2014) Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner. Cardiovasc Res. doi: 10.1093/cvr/cvu159
19. Moreau JL, Nabholz M, Diamantstein T, Malek T, Shevach E, et al. (1987) Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site. Eur J Immunol 17: 929-935.
20. Gao XM, Dart AM, Dewar E, Jennings G, Du XJ (2000) Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res 45: 330-338.
21. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, et al. (1998) Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274: H1812-1820.
22. Abbate A, Bussani R, Liuzzo G, Biondi-Zoccai GG, Barresi E, et al. (2008) Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. Heart 94: 737-742.
23. Betts RJ, Ho AW, Kemeny DM (2011) Partial depletion of natural CD4(+)CD25(+) regulatory Tcells with anti-CD25 antibody does not alter the course of acute influenza A virus infection. PLoS One 6: e27849.
24. Setiady YY, Coccia JA, Park PU (2010) In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol 40: 780-786.
25. Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, et al. (2006) Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176: 3301-3305.
26. Petzold C, Riewaldt J, Watts D, Sparwasser T, Schallenberg S, et al. (2013) Foxp3(+) regulatory T cells in mouse models of type 1 diabetes. J Diabetes Res 2013: 940710.
27. Zouggari Y, Ait-Oufella H, Waeckel L, Vilar J, Loinard C, et al. (2009) Regulatory T cells modulate postischemic neovascularization. Circulation 120: 1415-1425.
28. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, et al. (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197: 111-119.
29. O'Garra A, Vieira PL, Vieira P, Goldfeld AE (2004) IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378.
30. Sarangi PP, Sehrawat S, Suvas S, Rouse BT (2008) IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J Immunol 180: 6297-6306.
31. Sharir R, Semo J, Shaish A, Landa-Rouben N, Entin-Meer M, et al. (2014) Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner. Cardiovasc Res 103: 585-596.
32. Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110: 159-173.
33. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, et al. (2008) The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 127: 89-97.
34. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC (2007) Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2: e779.
35. Han SF, Liu P, Zhang W, Bu L, Shen M, et al. (2007) The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol 124: 90-97.
36. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, et al. (2011) Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 52: 382-387.
37. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455-1465.
38. Alyanakian MA, You S, Damotte D, Gouarin C, Esling A, et al. (2003) Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci U S A 100: 15806-15811.
39. McGeachy MJ, Stephens LA, Anderton SM (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175: 3025-3032.
40. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
41. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, et al. (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15: 192-199.
42. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD (2010) Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 77: 771-780.
43. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, et al. (2009) Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753.
44. Liu M, Chien CC, Grigoryev DN, Gandolfo MT, Colvin RB, et al. (2009) Effect of T cells on vascular permeability in early ischemic acute kidney injury in mice. Microvasc Res 77: 340-347.
45. Maisel A, Cesario D, Baird S, Rehman J, Haghighi P, et al. (1998) Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res 82: 458-463.